NCT00379847View on ClinicalTrials.gov

An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia

PHASE3CompletedINTERVENTIONAL
Enrollment

251

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Hyponatremia
Interventions
DRUG

conivaptan

IV

Trial Locations (28)

20007

Washington D.C.

29209

Columbia

30901

Augusta

45219

Cincinnati

49700

Petoskey

80262

Denver

85723

Tuscon

Unknown

Afula

Ashkelon

Hadera

2 Sites, Haifa

Holon

2 Sites, Jerusalem

Nahariya

Rehovot

2 Sites, Safed

Tel Aviv

Ẕerifin

Amanzimototi

Bellville

Bloemfontein

2 Sites, Durban

4 Sites, Johannesburg

Krugersdorp

Lyttelton

Pretoria

Somerset West

Soweto

Sponsors
All Listed Sponsors
lead

Cumberland Pharmaceuticals

INDUSTRY